← All trials
NCT04514302
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 20, 2020
- Primary completion
- Feb 20, 2021
- Completion date
- Jun 20, 2021
- First posted
- Aug 14, 2020
- Last posted
- Aug 14, 2020
- Enrollment
- 51
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Hospital San Jose Tec de MonterreyLead sponsor
- Hospital San Jose Tec de MonterreyReponsible party - principal investigator
- Inosan BiopharmaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.